Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma
British Journal of Haematology · 18.11.2026
DOI: 10.1111/bjh.70951 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 18.11.2026. Verfasst von Annamaria Vincenzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, Hematology Unit, Federico II University Medical School, Naples, Italy. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Real-world treatment burden of brentuximab vedotin-based frontline regimens in young adults and adults with advanced-stage classical Hodgkin lymphomaTo the Editor, We read with great enthusiasm the multicentre, retrospective study by Porges et al. in British Journal of Haematology in August 2026, 1 assessing front-line brentuximab vedotin, etoposide, cyclophosphamide, doxorubicin, dacarbazine, dexamethasone (BrECADD) in 100 advanced-stage classical Hodgkin lymphoma (cHL) patients (median age, 30 years).The outstanding disease control reported by the
Autor:innen und Institutionen
- Department of Clinical Medicine and Surgery, Hematology Unit, Federico II University Medical School, Naples, Italy.
- Department of Advanced Biomedical Sciences, Federico II University Medical School, Naples, Italy.
ORCID-Profile: Annamaria Vincenzi, Marco Picardi, Claudia Giordano, Novella Pugliese, Fabrizio Pane
Zitieren
APA
Vincenzi, A., Picardi, M., Giordano, C., Pugliese, N., Pellegrino, S., & Pane, F. (2026). Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.70951
Vancouver
Vincenzi A, Picardi M, Giordano C, Pugliese N, Pellegrino S, Pane F. Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma. British Journal of Haematology. 2026. doi:10.1111/bjh.70951
BibTeX
@article{Vincenzi2026,
author = {Vincenzi, Annamaria and Picardi, Marco and Giordano, Claudia and Pugliese, Novella and Pellegrino, Sara and Pane, Fabrizio},
title = {Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70951}
}
EUVIMED